J&J To Promote Dapoxetine With “Responsible” DTC Campaign
Executive Summary
Johnson & Johnson plans to support the launch of the premature ejaculation therapy dapoxetine with a "responsible" direct-to-consumer advertising campaign, J&J Consumer Pharmaceuticals & Nutritionals Group Chairman Rosemary Crane said May 26 during the company's R&D day in New York